Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
CBT 200 Moves Only A Point. More details...
CBT 200 Gives Up 20 Points. More details...
For a change, a China-based biopharma released a Q3...
The dollar value of China’s pharmaceutical market...
China's economy made an indelible impression on the world...
The ChinaBio® Stock Index, comprised of 17...
Fosun Pharmaceutical said it will raise up to 635 million...
Winteam Pharma will sell its 51% stake in Guizhou...
US Pharmacopeia, the not-for-profit organization that...
Sigma-Aldrich will build a new Asia-Pacific manufacturing...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China